Clincosm LogoSign in Get a demo

blastic plasmacytoid dendritic cell neoplasm (bpdcn)

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Patients Previously Treated WithMustang Bio CAR-T Cell

Enrolling by invitation
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • +10 more
  • Prior MB-102 CAR-T cell investigational product.
  • Prior MB-106 CAR-T cell investigational product.
  • Duarte, California
  • +4 more
Dec 8, 2022

Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in United States (MB-102, Fludarabine, Cyclophosphamide)

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • MB-102
  • +2 more
  • Duarte, California
  • +3 more
Jul 12, 2022

Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in Yerevan

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • Yerevan, Armenia
      Hematology Center named after prof. R. Yeolyan
    Jul 4, 2022

    Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • TregGraft (Orca-T)
    • Duarte, California
    • +13 more
    Oct 28, 2021

    Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Acute Myeloid Leukemia Trial in United States (SL-401)

    Completed
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • Acute Myeloid Leukemia
    • Duarte, California
    • +8 more
    Apr 6, 2020

    Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in Houston (UCART123)

    Terminated
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • UCART123
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 29, 2019